Sol-gel silica-based biomaterials and bone tissue regeneration

Acta Biomaterialia

Volumn 6, Issue 8, 2010, Pages 2874-2888

  Arcos, Daniel ^a   Vallet Regí, María ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Bioactive glasses; Drug delivery; Mesoporous materials; Sol gel; Tissue regeneration

Indexed keywords

BIOACTIVE GLASS; BIOMECHANICS; BONE; CONTROLLED DRUG DELIVERY; DEVELOPING COUNTRIES; ORGANIC-INORGANIC MATERIALS; SCAFFOLDS (BIOLOGY); SILICA; SOL-GEL PROCESS; SOL-GELS; SUPRAMOLECULAR CHEMISTRY; TARGETED DRUG DELIVERY; TISSUE REGENERATION;

BIOGLASSES; BONE DISEASE; BONE TISSUE REGENERATION; DRUG-DELIVERY SYSTEMS; NANOMETRIC SCALE; OSTEOCONDUCTIVE; OSTEOINDUCTIVE PROPERTIES; SILICA BASED MATERIALS; SOL'GEL; SOL-GEL SILICA;

MESOPOROUS MATERIALS;

3 METHACRYLOXYOPROPYL TRIMETHOXYSILANE; ALENDRONIC ACID; ANTIBIOTIC AGENT; ANTIESTROGEN; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BIOMATERIAL; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CALCIUM OXIDE; CALCIUM PHOSPHATE; GELATIN; GLASS; GROWTH FACTOR; NANOMATERIAL; ORMOSIL; POLY(TETRAMETHYLENE OXIDE); POLYMER; SILANE DERIVATIVE; SILICA GEL; SILICA MESOPOROUS MATERIAL; SILICATE; SILICON DERIVATIVE; SILICON DIOXIDE; SODIUM PEROXIDE; SOL GEL SILICA; SOMATOMEDIN C; TITANIUM DIOXIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINC;

BIOCOMPATIBILITY; BIODEGRADABLE IMPLANT; BONE GRAFT; BONE REGENERATION; BONE TISSUE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICAL COMPOSITION; CRYSTAL STRUCTURE; CRYSTALLIZATION; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG RELEASE; DRUG STABILITY; HUMAN; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; RABBIT; REVIEW; SUPRAMOLECULAR CHEMISTRY; TISSUE ENGINEERING; BONE; CHEMISTRY; GEL; PHYSIOLOGY; REGENERATIVE MEDICINE;

BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE REGENERATION; GELS; GLASS; REGENERATIVE MEDICINE; SILICON DIOXIDE;

EID: 77956625309     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2010.02.012     Document Type: Review

References (208)

1. Gentleman E, Polak JM. Historic and current strategies in bone tissue engineering: do we have a hope in Hench? J Mater Sci Mater Med 2006;17:1029-35.
2. Hench LL, Polack JM. Third-generation biomedical materials. Science 2002;295:1014.
3. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-6.
4. Wilson J, Yli-Urpo A, Happonen RP. In: Hench LL, Wilson J, editors. An introduction to bioceramics. Singapore: World Scientific; 1993. p. 63-73.
5. Hench LL, Wilson J. Surface-active biomaterials. Science 1984;226:630-6.
6. Hench LL, Splinter RJ, Greenlee T, Kand Allen WC. J Biomed Mater Res 1971;2:117.
7. Hench LL. Biomaterials. Science 1980;208:826-31.
8. Hench LL. Bioceramics - from concept to clinic. J Am Ceram Soc 1991;74:1487-510.
9. Xynos ID, Edgar AJ, Buttery LDK, Hench LL, Polak JM. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 2000;276:461-5.
10. Xynos ID, Hukkanen MVJ, Batten JJ, Buttery LD, Hench LL, Polak JM. Bioglass (R) 45S5 stimulates osteoblast turnover and enhances bone formation in vitro: implications and applications for bone tissue engineering. Calcif Tissue Int 2000;67:321-9.
11. Li R, Clark AE, Hench LL. An investigation of bioactive glass powders by sol-gel processing. J Appl Biomater 1991;2:231-9.
12. Brinker CJ, Scherer GW. Sol-gel science. San Diego, CA: Academic Press; 1990.
13. Hench LL, West JK. The sol-gel process. Chem Rev 1990;90:33-72.
14. Zarzycki J. Past and present of sol-gel science and technology. J Sol-Gel Sci Technol 1997;8:1-6.
15. Avnir D, Klein Lisa C, Levy D, Schubert U, Wojcik AB. Organo silica sol-gel materials. In: Apeloig Y, Rappoport A, editors. The chemistry of organosilicon compounds part 2. Chichester: Wiley & Sons; 1997.
16. Coradin T, Boissière M, Livage J. Sol-gel chemistry in medicinal science. Curr Med Chem 2006;13:99.
17. Avnir D, Coradin T, Lev O, Livage J. Recent bio-applications of sol-gel materials. J Mater Chem 2006;16:1013-30.
18. Zhong J, Greenspan DC. Processing and properties of sol-gel bioactive glasses. J Biomed Mater Res 2000;53:694-701.
19. Hamadouche M, Meunier A, Greenspan DC, Blanchat C, Zhong JP, La Torre GP, et al. Long term in vivo bioactivity and biodegradability of bulk sol-gel bioactive glasses. J Biomed Mater Res 2001;54:560-6.
20. Avnir D, Braun S. Biochemical aspects of sol-gel science and technology: a special issue of the journal o sol-gel science and technology. New York: Springer-Verlag; 1996.
21. Nieto A, Areva S, Wilson T, Viitala R, Vallet-Regí M. Cell viability in a wet silica gel. Acta Biomater 2009;5:3478-87.
22. Campostrini R, Carturam G. Immobilisation of plant cells in hybrid sol-gel material. J Sol-Gel Sci Technol 1996;7:87-97.
23. Pope Edgard JA. Bioartificial organs I: silica gel encapsulated pancreatic islets for the treatment of diabetes mellitus. J Sol-Gel Sci Technol 1997;8:635-9.
24. Vallet-Regí M. Revisiting ceramics for medical applications. Dalton Trans 2006;44:5211-20.
25. Vallet-Regí M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed 2007;46:7548-58.
26. Salinas AJ, Vallet-Regí M. Evolution of ceramics with medical applications. Z Anorg Allg Chem 2007;633:1762-73.
27. Vallet-Regí M. Nanoestructured mesoporous silica matrices in nanomedicine. J Intern Med 2010;267:22-43.
28. Vallet-Regí M, Balas F. Silica materials for medical applications. Open Biomed Eng J 2008;2:1-9.
29. Vallet-Regí M. Ceramics for medical applications. J Chem Soc Dalton Trans 2001:97-108.
30. Vallet-Regí M. Bone repair and regeneration possibilities. Materialwiss Werkst 2006;37:478-84.
31. Hench LL. The story of bioglass (R). J Mater Sci Mater Med 2006;17:967-78.
32. Hench LL, Andersson O. In: Hench LL, Wilson J, editors. Bioactive glasses. An introduction to bioceramics. Singapore: World Scientific Publishing; 1993. p. 41.
33. Pereira MM, Clark AE, Hench LL. Calcium-phosphate formation on sol-gelderived bioactive glasses in-vitro. J Biomed Mater Res 1994;28:693-8.
34. Vallet-Regí M, Arcos D, Pérez-Pariente J. Evolution of porosity during in vitro hydroxycarbonate apatite growth in sol-gel glasses. J Biomed Mater Res 2000;51:23-8.
35. Vallet-Regí M, Ragel CV, Salinas AJ. Glasses with medical applications. Eur J Inorg Chem 2003:1029-42.
36. Wheeler DL, Stokes KE. In vivo evaluation of sol-gel bioglass. Part I: histological findings. In: Transactions of the 23rd annual meeting of the society for biomaterials. New Orleans, La: Society for Biomaterials; 1997.
37. Silver IA, Erecinska M. Interactions of osteoblastic and other cells with bioactive glasses and silica in vitro and in vivo. Mat-wiss U Werkstofftech 2003;34:1069-75.
38. Hench LL, Xynos ID, Polak JM. Bioactive glasses for in situ tissue regeneration. J Biomater Sci Polymer Edn 2004;15:543-62.
39. Christodoulou I, Buttery LD, Saravanapavan P, Tai G, Hench LL, Polak JM. Dose- and time-dependent effect of bioactive gel-glass ionic-dissolution products on human fetal osteoblast-specific gene expression. J Biomed Mater Res B Appl Biomater 2005; 74B: 529-37.
40. Christodoulou I, Buttery LD, Tai G, Hench LL, Polak JM. Characterization of human fetal osteoblasts by microarray analysis following stimulation with 58S bioactive gel-glass ionic dissolution products. J Biomed Mater Res B Appl Biomater 2006; 77B: 431-46.
41. Bielby RC, Christodoulou IS, Pryce RS, Radford WJ, Hench LL, Polak JM. Timeand concentration-dependent effects of dissolution products of 58S sol-gel bioactive glass on proliferation and differentiation of murine and human osteoblasts. Tissue Eng 2004;10:1018-26.
42. Arcos D, Greenspan DC, Vallet-Regí M. A new quantitative method to evaluate the in vitro bioactivity of melt and sol-gel derived silicate glasses. J Biomed Mater Res 2003; 65A: 344-51.
43. Hill R. An alternative view of the degradation of bioglass. J Mater Sci Lett 1996;15:1122-5.
44. Greenspan DC, Hench LL. Chemical and mechanical-behavior of bioglasscoated alumina. J Biomed Mater Res 1976;10:503-9.
45. Gross UM, Strunz V. The anchoring of glass-ceramics of different solubility in the femur of the rat. J Biomed Mater Res 1980;14:607-18.
46. Gross U, Strunz V. The interface of various glasses and glass-ceramics with a bony implantation bed. J Biomed Mater Res 1985;19:251-71.
47. Zhong J, La Torre GP, Greenspan DC, Hench LL. Aluminium inhibitory effect on the formation of hydroxyapatite. Bioceramics 1995;8:489-92.
48. Rámila A, Balas F, Vallet-Regí M. Synthesis routes for bioactive sol-gel glasses: alkoxides vs. nitrates. Chem Mater 2002;14:542-8.
49. Vallet-Regí M, Pérez-Pariente J, Izquierdo-Barba I, Salinas AJ. Composition variations in the calcium phosphate layer growth on gel glasses soaked in a simulated body fluid. Chem Mater 2000;12:3770-5.
50. Vallet-Regí M, Rámila A. New bioactive glass and changes in porosity during the growth of a carbonate hydroxyapatite layer on glass surface. Chem Mater 2000;12:961-5.
51. Salinas AJ, Vallet-Regí M, Izquierdo-Barba I. Biomimetic apatite deposition on calcium silicate gel glasses. J Sol-Gel Sci Technol 2001;21:13-25.
52. Vallet-Regí M, Martín AI, Salinas AJ, Olmo N, Turnay J, Lizarbe MA. In vitro behaviour of bioactive sol-gel glasses. Biol Cell 2001;93:328-9.
53. Rámila A, Vallet-Regí M. Static and dynamic in vitro study of a sol-gel glass bioactivity. Biomaterials 2001;22:2301-6.
54. 2 sol-gel glass. J Biomed Mater Res 2000;51:191-9.
55. Olmo N, Martín AI, Salinas AJ, Turnay J, Vallet-Regí M, Lizarbe MA. Bioactive sol-gel glasses with and without a hydroxycarbonate apatite layer as substrates for osteoblast cell adhesion and proliferation. Biomaterials 2003;24:3383-93.
56. Meseguer-Olmo L, Ros-Nicolás MJ, Clavel-Sainz M, Vicente-Ortega V, Alcaraz Baños M, Lax-Pérez A, et al. Biocompatibility and in vivo gentamicin release from bioactive sol-gel glass implants. J Biomed Mater Res 2002;61:458-65.
57. Gil-Albarova J, Garrido-Lahigvera R, Salinas AJ, Roman J, Bueno-Lozano AL, Gil-Albarova R, et al. The in vivo performance of a sol-gel glass and a glassceramic in the treatment of limited bone defects. Biomaterials 2004;25:4639-45.
58. Gil-Albarova J, Salinas A, Bueno-Lozano AL, Román J, Aldini-Nicolo N, García-Barea A, et al. The in vivo behaviour of a sol-gel glass and a glass-ceramic during critical diaphyseal bone defects healing. Biomaterials 2005;26:4374-82.
59. 5 sol-gel glasses. Chem Mater 2002;14:1515-22.
60. 5 glasses prepared by the sol-gel method. J Mater Res 2001;16:1345-8.
61. 2 solgel glasses. J Biomed Mater Res 2002;61:524-32.
62. 2. J Biomed Mater Res 1999;47:243-50.
63. 2 binary glasses system. Chem Mater 2000;12:3080-8.
64. Padilla S, Román J, Carenas A, Vallet-Regí M. Influence of the phosphorus content on the bioactivity in sol-gel glass ceramics. Biomaterials 2005;26:475-83.
65. 5 sol-gel glasses. J Mater Chem 1999;9:515-8.
66. 5-MgO sol-gel glasses. J Biomed Mater Res 1999;47:170-5.
67. 2 system. Biomaterials 2000;21:251-7.
68. 5CaO (MgO) bioactive glasses. Chem Mater 2000;12:750-5.
69. 5-MgO bioglass. Mater Sci Eng C 2009;29:335-40.
70. Bellantone M, Coleman NJ, Hench LL Bacteriostatic action of a novel four component bioactive glass. J Biomed Mater Res 2000;51:484-90.
71. 2 glass prepared by sol-gel method. J Mater Sci Mater Med 2004;15:831-7.
72. Jones JR, Ehrenfried LM, Saravanapavan P, Hench LL Controlling ion release from bioactive glass foam scaffolds with antibacterial properties. J Mater Sci Mater Med 2006;17:989-96.
73. Courtheoux L, Lao J, Nedelec JM, Jallot E. Controlled bioactivity in zinc-doped sol-gel-derived binary bioactive glasses. J Phys Chem C 2008;112:13663-7.
74. 2-CaO-ZnO glasses and ceramics. J Biomed Mater Res 2007; 82A: 575-88.
75. Varmette EA, Nowalk JR, Flick LM, Hall MM. Abrogation of the inflammatory response in LPS-stimulated RAW 264.7 murine macrophages by Zn- and Cudoped bioactive sol-gel glasses. J Biomed Mater Res 2009; 90A: 317-25.
76. Lao J, Jallot E, Nedelec JM. Strontium-delivering glasses with enhanced bioactivity: a new biomaterial for antiosteoporotic applications? Chem Mater 2008;20:4969-73.
77. Ragel CV, Vallet-Regí M. In vitro bioactivity and gentamicin release from glass-polymer-antibiotic composites. J Biomed Mater Res 2000;51:424-9.
78. Arcos D, Ragel CV, Vallet-Regi M. Bioactivity in glass/pmma composites used as drug delivery system. Biomaterials 2001;22:701-8.
79. Ladrón de Guevara S, Ragel CV, Vallet-Regí M. Bioactive glass-polymer materials for controlled release of ibuprofen. Biomaterials 2003;24:4037-43.
80. 5 sol-gel on the bioactivity and controlled release of a ceramic/polymer/antibiotic mixed materials. Chem Mater 2003;15:4132-8.
81. Arcos D, del Real RP, Vallet-Regí M. A novel bioactive and magnetic biphasic material. Biomaterials 2002;23:2151-8.
82. Arcos D, del Real RP, Vallet-Regí M. Biphasic materials for bone grafting and hyperthermia treatment of cancer. J Biomed Mater Res 2003; 65A: 71-8.
83. 3 solid solutions. Chem Mater 2002;14:64-70.
84. Ruiz E, Serrano MC, Arcos D, Vallet-Regí M. Glass-glass ceramic thermoseeds for hyperthermic treatment of bone tumours. J Biomed Mater Res 2006; 79A: 533-43.
85. Serrano MC, Portoles MT, Pagani R, Sáez de Guinoa J, Ruíz-Fernández E, Arcos D, et al. In vitro positive biocompatibility evaluation of glass-glass ceramic thermoseeds for hyperthermic treatment of bone tumours. Tissue Eng 2008;14:617-27.
86. Ragel CV, Vallet-Regí M, Rodríguez-Lorenzo LM. Preparation and in vitro bioactivity of hydroxyapatite/solgel-glass biphasic material. Biomaterials 2002;23:1865-72.
87. Vallet-Regí M, Rámila A, Padilla S, Muñoz B. Bioactive glasses as accelerators of the apatites bioactivity. J Biomed Mater Res 2003;66:580-5.
88. Roman J, Padilla S, Vallet-Regí M. Sol-gel glasses as precursors of bioactive glass-ceramics. Chem Mater 2003;15:798-806.
89. 5 glass-ceramics. J Mater Chem 2005;15:1353-9.
90. 5. Acta Biomater 2008;4:1104-13.
91. 2 hybrids prepared by sol-gel process. Biomaterials 1999;20:1127-32.
92. Sanchez C, Lebeau B, Chaput F, Boilot JP. Optical properties of functional hybrid organic-inorganic nanocomposites. Adv Mater 2003;15:1969-94.
93. Sanchez C, Julián B, Belleville P, Popall M. Applications of hybrid organic-inorganic nanocomposites. J Mater Chem 2005;15:3559-92.
94. Mackenzie JD. Structures and properties of ormosils. J Sol-Gel Sci Techol 1994;2:81.
95. Tsuru K, Ohtsuki C, Osaka A, Mackenzie Iwamoto T. Bioactivity of sol-gel derived organically modified silicates. J Mater Sci Mater Med 1997;8:157-61.
96. Colilla M, Salinas AJ, Vallet-Regí M. Amino-polysiloxane hybrid materials for bone reconstruction. Chem Mater 2006;18:5676-83. (Pubitemid 44893452)
97. Julian B, Gervais C, Cordoncillo E, Escribano P, Babonneau F, Sanchez C. Síntesis and characterization of transparent PDMS-Metal-Oxo based organic-inorganic nanocomposites. Chem Mater 2003;15:3026-34.
98. 3+-doped inorganic-organic hybrid materials based on siloxane networks. J Mater Chem 2004;14:3337-43.
99. Vallet-Regí M, Arcos D. Nanostructured hybrid materials for bone tissue regeneration. Curr Nano 2006;2:179-89. (Pubitemid 44249558)
100. Sanchez C, Ribot F. Design of hybrid organic-inorganic materials synthesized via sol-gel chemistry. New J Chem 1994;18:1007-47.
101. Manzano M, Salinas AJ, Gil FJ, Vallet-Regí M. Mechanical properties of organically modified silicates for bone regeneration. J Mater Sci Mater Med 2009;20:1795-801.
102. Mammeri F, Le Bourhis E, Rozes L, Sanchez C. Mechanical properties of hybrid organic-inorganic materials. J Mater Chem 2005;15:3787-811.
103. 2 hybrid sol-gel material. J Biomed Mater Res Appl Biomater 1997;38:143-54.
104. Rhee S, Choi J. Preparation of a bioactive poly (methyl methacrylate)/silica nanocomposite. J Am Ceram Soc 2002;85:1318-20. (Pubitemid 34566784)
105. Jones SM, Friberg SE, Sjoblom J. A bioactive composite-material produced by the sol-gel method. J Mater Sci 1994;29:4075-80.
106. Yamamoto S, Miyamoto T, Kokubo T, Nakamura T. Preparation of polymersilicate hybrid materials bearing silanol groups and the apatite formation on/in the hybrid materials. Polym Bull 1998;40:243-50.
107. 2 PDMS hybrids for use in implants. J Biomed Mater Res B 2007;81B:274-82.
108. 2 hybrids. J Mater Sci Mater Med 2003;14:1067-72.
109. 2 hybrids by the sol-gel method. J Sol-Gel Sci Technol 2000;19:101-5.
110. 2 hybrids via sol-gel processing: their apatiteforming ability and mechanical properties. J Ceram Soc Jpn 2003;111:555-9.
111. Chen Q, Miyata N, Kokubo T. Bioactivity and mechanical properties of poly (dimethylsiloxane)-modified calcia-silica hybrids with added titania. J Am Ceram Soc 2003;86:806-10.
112. 2 hybrids prepared by sol-gel processing: effect of CaO and PTMO contents. Biomaterials 2002;23:3033-40.
113. 2 hybrids prepared by sol-gel process. J Biomed Mater Res 2000;51:605-11.
114. 2 hybrids treated with hot water. Biomaterials 2003;24:1357-63.
115. 2 hybrids derived from sol-gel processing. Biomaterials 2004;25:1-7.
116. Manzano M, Salinas AJ, Vallet-Regí M. P-containing ormosils for bone reconstruction. Prog Solid State Chem 2006;34:267-77.
117. Vallet-Regí M, Salinas AJ, Ramírez-Castellanos J, González-Calbet JM. Nanostructure of bioactive sol-gel glasses and organic-inorganic hybrids. Chem Mater 2005;17:1874-9.
118. Salinas AJ, Vallet-Regí M, Toledo-Fernández JA, Mendoza-Serna R, Piñero M, Esquivias L, et al. Nanostructure and bioactivity of hybrid aerogels. Chem Mater 2009;21:41-7.
119. Martín AI, Salinas AJ, Vallet-Regí M. Bioactive and degradable organic-inorganic hybrids. J Eur Ceram Soc 2005;25:3533-8.
120. González B, Colilla M, Vallet-Regí M. Time-delayed release of bioencapsulates: a novel controlled delivery concept for bone implant technologies. Chem Mater 2008;20:4826-34.
121. Ohtsuki C, Miyazaki T, Tanihara M. Development of bioactive organic-inorganic hybrid for bone substitutes. Mater Sci Eng C 2002;22:27-34.
122. 2 hybrid gels: effects of catalysts in the sol-gel processing on mechanical properties and in vitro hydroxyapatite formation in a simulated body fluid. J Biomater Appl 2009;23:519-32.
123. Ren L, Tsuru K, Hayakawa S, Osaka A. Synthesis and characterization of gelatin-siloxane hybrids derived through sol-gel procedure. J Sol-Gel Sci Technol 2001;21:115-21. (Pubitemid 32512188)
124. Ren L, Tsuru K, Hayakawa S, Osaka A. Sol-gel preparation and in vitro deposition of apatite on porous gelatin-siloxane hybrids. J Non-Cryst Solids 2001;285:116-22.
125. Ren L, Tsuru K, Hayakawa S, Osaka A. Novel approach to fabricate porous gelatin-siloxane hybrids for bone tissue engineering. Biomaterials 2002;23:4765-73.
126. Ren L, Tsuru K, Hayakawa S, Osaka A. In vitro evaluation of osteoblast response to sol-gel derived gelatin-siloxane hybrids. J Sol-Gel Sci Technol 2003;26:1137-40.
127. Rhee SH, Choi JY, Kim HM. Preparation of a bioactive and degradable poly (ε-caprolactone)/silica hybrid through a sol-gel method. Biomaterials 2002;23:4915-21.
128. Rhee SH. Bone-like apatite-forming ability and mechanical properties of poly (ε-caprolactone)/silica hybrid as a function of poly (ε-caprolactone) content. Biomaterials 2004;25:1167-75.
129. Rhee SH. Effect of calcium salt content in the poly (ε-caprolactone) /silica nanocomposite on the nucleation and growth behavior of apatite layer. J Biomed Mater Res 2003; 67A: 1131-8.
130. Sharp KG, Michalczyk MJ. Star gels: new hybrid network materials from polyfunctional single component precursors. J Sol-Gel Sci Technol 1997;8:541-6.
131. Sharp KG. Inorganic/organic hybrid materials. Adv Mater 1998;10:1243-8.
132. Manzano M, Arcos D, Rodríguez Delgado M, Ruiz E, Gil FJ, Vallet-Regí M. Bioactive star gels. Chem Mater 2006;18:5696-703.
133. Varvani-Farahani A, Najmi H. A damage assessment model for cadaveric cortical bone subjected to fatigue cycles. Int J Fatigue 2010;32:420-7.
134. Vallet-Regí M, Ruiz-González L, Izquierdo-Barba I, González-Calbet JM. Revisiting silica based ordered mesoporous materials: medical applications. J Mater Chem 2006;16:26-31.
135. Izquierdo-Barba I, Colilla M, Vallet-Regí M. Nanostructured mesoporous silicas for biomedical applications. J Nanomater 2008;14:106970.
136. Vila M, Hueso JL, Manzano M, Izquierdo-Barba I, de Andrés A, Sánchez-Marcos J, et al. Carbon nanotubes-mesoporous silica composites as controllable biomaterials. J Mater Chem 2009;19:7745-52.
137. Bass JD, Grosso D, Boissiere C, Belamie E, Coradin T, Sanchez C. Stability of mesoporous oxide and mixed metal oxide materials under biologically relevant conditions. Chem Mater 2007;19:4349-56.
138. Sanchez C, Boissière C, Grosso D, Alberti C, Nicole L. Design, synthesis, and properties of inorganic and hybrid thin films having periodically organized nanoporosity. Chem Mater 2008;20:682-737.
139. Colilla M, Izquierdo-Barba I, Vallet-Regí M. Novel biomaterials for drug delivery. Expert Opin Ther Patents 2008;18:639-56.
140. Colilla M, Manzano M, Vallet-Regí M. Recent advances in ceramic implants as drug delivery systems for biomedical applications. Int J Nanomed 2008;3:403-14.
141. Manzano M, Colilla M, Vallet-Regí M. Drug delivery from ordered mesoporous matrices. Expert Opin Drug Deliv 2009;6:1-18.
142. Vallet-Regí M, Colilla M, Izquierdo-Barba I. Bioactive mesoporous silicas as controlled delivery systems: application in bone tissue regeneration. J Biomed Nanotechnol 2008;4:1-15.
143. Vallet-Regí M. Ordered mesoporous materials in the context of drug delivery systems and tissue engineering. Chem Eur J 2006;12:5934-43.
144. Firouzi A, Atef F, Oaertly AG, Stucky GD, Chmelka BF. Alkaline lyotropic silicate-surfactant liquid crystals. J Am Chem Soc 1997;119:3596-610.
145. Vallet-Regí M, Rámila A, del Real RP, Pérez-Pariente J. A new property of MCM-41: drug delivery system. Chem Mater 2001;13:308-11.
146. Vallet-Regí M, Doadrio JC, Doadrio AL, Izquierdo-Barba I, Pérez-Pariente J. Hexagonal ordered mesoporous material as a matrix for the controlled release of amoxicillin. Solid State Ionics 2004;172:435-9.
147. Vallet-Regí M, Balas F, Colilla M, Manzano M. Bioceramics and pharmaceuticals: a remarkable synergy. Solid State Sci 2009;9:768-76.
148. Vallet-Regí M, Balas F, Colilla M, Manzano M. Drug confinement and delivery in ceramic implants. Drug Metab Lett 2007;1:37-40.
149. Rámila A, Muñoz B, Pérez-Pariente J, Vallet-Regí M. Mesoporous MCM-41 as drug host system. J Sol-gel Sci Technol 2003;26:1199-202.
150. Al Doadrio, Sousa EMB, Doadrio JC, Pérez-Pariente J, Izquierdo-Barba I, Vallet-Regí M. Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery. J Control Release 2004;97:125-32.
151. Babonneau F, Camus L, Steunou N, Ramila A, Vallet-Regí M. Encapsulation of ibuprofen in mesoporous silica: solid state NMR characterization. Mater Res Soc 2003;775:3261-6.
152. Babonneau F, Yeung L, Steunou N, Gervais C, Ramila A, Vallet-Regí M. Solid state NMR characterisation of encapsulated molecules in mesoporous silica. J Sol-Gel Sci Technol 2004;31:219-23.
153. Di Renzo F, Testa F, Chen JD, Cambon H, Galarneau A, Plee D, et al. Textural control of micelle-templated mesoporous silicates: the effects of co-surfactants and alkalinity. Micropor Mesopor Mater 1999;28:437-46.
154. Khushalani D, Kuperman A, Ozin GA, Tanaka K, Garces J, Olken MM, et al. Metamorphic materials-restructuring siliceous mesoporous materials. Adv Mater 1995;7:842-6.
155. Horcajada P, Rámila A, Pérez-Pariente J, Vallet-Regí M. Influence of pore size of MCM-41 matrices on drug delivery rate. Micropor Mesopor Mater 2004;68:105-9.
156. Izquierdo-Barba I, Sousa E, Doadrio JC, Doadrio AL, Pérez Pariente J, Martínez A, et al. Influence of mesoporous structure type on the controlled delivery of drugs: release of ibuprofen from MCM-48, SBA-15 and functionalized SBA-15. J Sol-Gel Sci Technol 2009;50:421-4.
157. Manzano M, Aina V, Arean CO, Balas F, Cauda V, Colilla M, et al. Studies on MCM-41 mesoporous silica for drug delivery: effect of particle morphology and amine functionalization. Chem Eng J 2008;137:30-7.
158. Izquierdo-Barba I, Vallet-Regí M, Kupferschmidt N, Terasaki O, Schmidtchen A, Martin Malmsten. Incorporation of antimicrobial compounds in mesoporous silica film monolith. Biomaterials 2009;30:5729-36.
159. Balas F, Manzano M, Horcajada P, Vallet-Regí M. Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials. J Am Chem Soc 2006;128:8116-7.
160. Colilla M, Balas F, Manzano M, Vallet-Regí M. Novel method to enlarge the surface area of SBA-15. Chem Mater 2007;19:3099-101.
161. Colilla M, Balas F, Manzano M, Vallet-Regí M. Novel method to synthesize ordered mesoporous silica with high surface areas. Solid State Sci 2008;10:408-15.
162. 2 leaching in water. Chem Mater 2009;21:4135-45.
163. Muñoz B, Rámila A, Pérez-Pariente J, Díaz I, Vallet-Regí M. MCM-41 organic modification as drug delivery rate regulator. Chem Mater 2003;15:500-3.
164. Hoffmann F, Cornelius M, Morell J, Fröba M. Silica-based mesoporous organic-inorganic hybrid materials. Angew Chem Int Ed 2006;45:3216-51.
165. Tourné-Péteilh C, Brunel D, Bégu S, Chiche B, Fajula F, Lerner DA, et al. Synthesis and characterisation of ibuprofen-anchored MCM-41 silica and silica gel. New J Chem 2003;27:1415-8.
166. Nieto A, Balas F, Colilla M, Manzano M, Vallet-Regí M. Functionalization degree of SBA-15 as key factor to modulate sodium alendronate dosage. Micropor Mesopor Mater 2008;116:4-13.
167. Colilla M, Manzano M, Izquierdo-Barba I, Vallet-Regí M, Boissiére C, Sanchez C. Advanced drug delivery vectors with tailored surface properties made of mesoporous binary oxides submicronic spheres. Chem Mater. doi:10.1021/cm9033484.
168. Izquierdo-Barba I, Martínez A, Doadrio AL, Pérez-Pariente J, Vallet-Regí M. Release evaluation of drugs from ordered three-dimensional silica structures. Eur J Pharm Sci 2005;26:365-73.
169. Doadrio JC, Sousa EMB, Izquierdo-Barba I, Doadrio AL, Pérez-Pariente J, Vallet-Regí M. Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern. J Mater Chem 2006;16:462-6.
170. Tang Q, Xu Y, Wu D, Sun Y. Hydrophobicity-controlled drug delivery system from organic modified mesoporous silica. Chem Lett 2006;35:474-5. (Pubitemid 44154218)
171. González B, Colilla M, López Laorden C, Vallet-Regí M. A novel synthetic strategy for covalently bonding dendrimers to ordered mesoporous silica: potential drug delivery applications. J Mater Chem 2009;19:9012-24.
172. Carter DC, Ho JX. Structure of serum-albumin. Adv Protein Chem 1994;45:153-203.
173. Peters T. All about albumin: biochemistry, genetics and medical applications. San Diego: Academic Press; 1995.
174. Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K. Crystal structure of human serum albumin at 2.5 angstrom resolution. Protein Eng 1999;12:439-46.
175. Suva LJ, Winslow GA, Wettenhall R, Hammonds RG, Moseley JM, Diefenbachjagger H. A parathyroid hormona-related protein implicated in malignant hypercalcemia: coloning and expresión. Science 1987;237:893-6.
176. Balas F, Manzano M, Colilla M, Vallet-Regí M. L-trp adsorption into silica mesoporous materials to promote bone formation. Acta Biomater 2008;4:514-22.
177. Lozano D, Manzano M, Doadrio JC, Salinas AJ, Vallet-Regí M, Gómez-Barrena E, et al. Osteostatin-loaded bioceramics stimulate osteoblastic growth and differentiation. Acta Biomater 2010;6:797-803.
178. Horcajada P, Rámila A, Boulahya K, González-Calbet J, Vallet-Regí M. Bioactivity in ordered mesoporous materials. Solid State Sci 2004;6:1295-300.
179. Izquierdo-Barba I, Ruiz-González L, Doadrio JC, González-Calbet JM, Vallet-Regí M. Tissue regeneration: a new property of mesoporous materials. Solid State Sci 2005;7:983-9.
180. Yan XX, Yu CZ, Zhou XF, Tang JW, Zhao DY. Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities. Angew Chem Int Ed 2004;43:5980-4.
181. Yan XX, Huang XH, Yu CZ, Deng HX, Wang Y, Zhang ZD, et al. The in-vitro bioactivity of mesoporous bioactive glasses. Biomaterials 2006;27:3396-403.
182. López-Noriega A, Arcos D, Izquierdo-Barba I, Sakamoto Y, Terasaki O, Vallet-Regí M. Ordered mesoporous bioactive glasses for bone tissue regeneration. Chem Mater 2006;18:3137-44.
183. Izquierdo-Barba I, Arcos D, Sakamoto Y, Terasaki O, López-Noriega A, Vallet-Regí M. High-performance mesoporous bioceramics mimicking bone mineralization. Chem Mater 2008;20:3191-8.
184. Leonova E, Izquierdo-Barba I, Arcos D, López-Noriega A, Hedi N, Vallet-Regí M, et al. Multinuclear solid-state NMR studies of ordered mesoporous bioactive glasses. J Phys Chem C 2008;112:5552-62.
185. 5 mesoporous bioactive glasses. Chem Mater 2009;21:5474-84.
186. Alcaide M, Portolés P, López-Noriega A, Arcos D, Vallet-Regí M, Portoles MT. Interaction of an ordered mesoporous bioactive glass with osteoblasts, fibroblasts and lymphocytes demonstrates its biocompatibility as a potential bone graft material. Acta Biomater 2010;6:892-9.
187. Gómez Gil V, Trejo C, García-Honduvilla N, Lozano D, Bellido M, Doadrio JC, et al. Mimetic biomaterials in compromised bone repair: PTHrP peptide (107-111)-releasing silica mesoporus biomaterial improves bone neoformation in an experimental model of osteoporosis. In: 22nd European conference on biomaterials, Lausanne, Switzerland, September 7-11, 2009.
188. Frieb W, Werner J. Biomedical applications. In: Shüth F, KIenneth S, Sing W, Kamps W, editors. Handbook of porous solids. Weinheim, Germany: Wiley-VCH; 2000. p. 2923-70.
189. Sánchez-Salcedo S, Werner J, Vallet-Regí M. Hierarchical pore structure of calcium phosphate scaffolds by combination of the gel casting and multiple tape casting methods. Acta Biomater 2008;4:913-22.
190. Rho JY, Kuhn-Spearing L, Zioupos P. Mechanical properties and the hierarchical structure of bone. Med Eng Phys 1998;20:92-102.
191. Hollister SJ. Porous scaffold design for tissue engineering. Nat Mater 2005;4:518-24.
192. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005;26:5474-91.
193. Zhang K, Yan HW, Bell DC, Stein A, Francis LF. Effects of materials parameters on mineralization and degradation of sol-gel bioactive glasses with 3D-ordered macroporous structures. J Biomed Mater Res 2003; 66A: 860-9.
194. 2 sol-gel glasses with a threedimensionally ordered macroporous structure. Chem Mater 2001;13:1374-82.
195. Jones JR, Hench LL. Regeneration of trabecular bone using porous ceramics. Curr Opin Solid State Sci 2003;7:301-7.
196. Jones JR, Hench LL. Effect of surfactant concentration and composition on the structure and properties of sol-gel derived bioactive glass foam scaffolds for tissue engineering. J Mater Sci 2003;38:3783-90.
197. Sepúlveda P, Jones JR, Hench LL. Bioactive sol-gel foams for tissue repair. J Biomed Mater Res 2002;59:340-8.
198. Valerio P, Guimaraes MHR, Pereira MM, Leite MF, Goes AM. Primary osteoblast cell response to sol-gel derived bioactive glass foams. J Mater Sci Mater Med 2005;16:851-6.
199. Jones JR. New trends in bioactive scaffolds: the importance of nanostructure. J Eur Ceram Soc 2009;29:1275.
200. Yun HS, Kim SE, Hyeon YT. Design and preparation of bioactive glasses with hierarchical pore networks. Chem Commun 2007:2139-41.
201. Yeong WY, Chua CK. Rapid prototyping in tissue engineering: challenges and potential. Trends Biotechnol 2004;22:643-52.
202. Xie B, Parkhill RL, Warren WL, Smay JE. Direct writing of three-dimensional polymer scaffolds using colloidal gels. Adv Funct Mater 2006;16:1685-93.
203. Li X, Wang X, Chen H, Jiang P, Dong X, Shi J. Hierarchically porous bioactive glass scaffolds synthesized with a PUF and P123 cotemplated approach. Chem Mater 2007;19:4322-6.
204. Zhu Y, Wu C, Ramaswamy Y, Kockrick E, Simon P, Kaskel S, et al. Preparation, characterization and in vitro bioactivity of mesoporous bioactive glasses (MBGs) scaffolds for bone tissue engineering. Micropor Mesopor Mater 2008;112:494-503.
205. 16) scaffold with biomimetic apatite layer for bone tissue engineering. J Mater Sci Mater Med 2007;18:857-64.
206. Valerio P, Pereira MM, Goes AM, Leite MF. The effect of ionic products from bioactive glass dissolution on osteoblast proliferation and collagen production. Biomaterials 2004;25:2941-8.
207. Vallet-Regí M. Current trends on porous inorganic materials for biomedical applications. Chem Eng J 2007;137:1-3.
208. Baeza A, Izquierdo-Barba I, Vallet-Regí M. Biotinylation of silicon-doped hydroxyapatite: a new approach to protein fixation for bone tissue regeneration. Acta Biomater 2010;6:743-9.